Cavium (CAVM) Tops Q4 EPS by 5c, Sales Fall Inline

Cavium (NASDAQ: CAVM) reported Q4 non-GAAP EPS of $0.17, $0.05 better than the analyst estimate of $0.12. Revenue for the quarter came in at $56.3 million versus the consensus estimate of $56.58 million.

For earnings history and earnings-related data on Cavium (CAVM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Cosmos Health posts 29% revenue rise in Q2 but net loss widens
• Benchmark Reiterates Hold Rating on Bio-Techne Corp. (TECH)